SCHEMBL7354341

SCHEMBL7354341

CC(C)(c1ccccc1)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
NQO1 P15559 5/20 0.50
CYP2C9 P11712 4/20 0.50
ALDH1A1 P00352 3/20 0.50
VKORC1 Q9BQB6 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
PCSK7 Q16549 2/20 0.50
ABCB11 O95342 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
PDE4D Q08499 1/20 0.50
GPR35 Q9HC97 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12747979 0.84 KDM4E (0.62) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL7362388 0.83 CA12 (0.48) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL9286035 0.81 NQO1 (0.53) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL12091846 0.79 CA12 (0.49) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL1649890 0.78 NQO1 (0.50) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL1095043 0.78 KDM4E (0.57) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL15514111 0.77 ALDH1A1 (0.51) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL5103338 0.77 NQO1 (0.52) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL3778823 0.77 ALDH1A1 (0.51) KDM4ECA12CA9NQO1CYP2C9
SCHEMBL9214360 0.77 NQO1 (0.52) KDM4ENQO1CYP2C9ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP claimed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 US claimed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP claimed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO claimed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 US disclosed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP disclosed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO disclosed